MRK provided 2025 adjusted EPS guidance of $8.88 to $9.03, while the giant drugmaker expects sales of $64.1 billion to $65.6 ...

Merck's stock tumbled 11.8% Tuesday, putting it on track for its biggest one-day selloff in almost 17 years, after the drug company's softer-than-expected guidance amid struggles for its HPV vaccine ...

Rahway, N.J.-based Merck (MRK) had net income of $3.743 billion, or $1.48 a share, for the quarter, after a loss of $1.226 ...

Medicare and Cigna don't cover this medication anymore. Her bills are rent $62 ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Those 10 lower prices – which ranged from a price cut of 79% for Type 2 diabetes drug Januvia to a 38% cut for cancer drug Imbruvica – will go into effect in January 2026. That means for ...

While some companies increased prices, others cut the list prices. For example, MSD cut the list price of its popular diabetes drugs, Januvia (sitagliptin) and Janumet (sitagliptin + metformin), by 42 ...

Eating pasta and pizza in Italy is better for your blood sugar levels than consuming them in America, a health reporter has demonstrated. Emily Joshu Sterne has discovered that her blood sugar levels ...

Researchers from Saint John of God Hospital in Dublin have published the guidance following the Appraisal of Guidelines for Research and Evaluation II instrument (AGREE II). The authors said: “The ...

and sitaglipt (Januvia), a diabetes drug. “We don’t know that much about what the exposures or health risks are” for those drinking small concentrations of this material, Ruyle said. “This study ...